Results 31 to 40 of about 3,418,065 (230)

Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys

open access: yesFrontiers in Endocrinology, 2022
Thyroid cancer is the malignant tumor that is increasing most rapidly in the world, mainly at the expense of sporadic papillary thyroid carcinoma. The somatic alterations involved in the pathogenesis of sporadic follicular cell derived tumors are well ...
María Sánchez-Ares   +9 more
doaj   +1 more source

Advanced medullary thyroid cancer: pathophysiology and management [PDF]

open access: yes, 2013
Carla Vaz Ferreira, Débora Rodrigues Siqueira, Lucieli Ceolin, Ana Luiza MaiaThyroid Section, Endocrine Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, BrazilAbstract: Medullary thyroid carcinoma (MTC) is a rare malignant ...
Ceolin L   +3 more
core   +2 more sources

“Triple-negative” non-secretory medullary thyroid cancer: uncommon pathological findings in a rare disease

open access: yes, 2022
Medullary thyroid cancer (MTC) is a neuroendocrine tumor that arises from the calcitonin (CT)-producing thyroid parafollicular C cells, accounting for 3–4% of all thyroid cancers [1, 2].
Martínez-Montoro, José Ignacio   +17 more
core   +1 more source

Medullary thyroid cancer: a little history

open access: yesMìžnarodnij Endokrinologìčnij Žurnal, 2022
The literature review presents the history on the deve­lopment of modern ideas about medullary thyroid cancer, which is a little more than fifty years.
S.Y. Rybakov
doaj   +1 more source

Vandetanib for the Treatment of Metastatic Medullary Thyroid Cancer [PDF]

open access: yes, 2012
Medullary thyroid cancer (MTC) represents an aggressive form of thyroid malignancy. Some may occur spontaneously or can be associated with Multiple Endocrine Neoplasia syndromes, or Familial Medullary Thyroid Cancer syndrome.
Nils Degrauwe   +12 more
core   +1 more source

A Phase 2 Trial of the Multi-targeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC) [PDF]

open access: yes, 2015
Positive results of phase 1 studies evaluating lenvatinib in solid tumors including thyroid cancer prompted a phase 2 trial in advanced medullary thyroid carcinoma (MTC)
Mccaffrey, Judith   +60 more
core   +1 more source

Preventive Transoral Endoscopic Thyroidectomy by Vestibular Approach in 6-Year-Old Patient with the High-Risk RET C634R Germline Mutation

open access: yesCase Reports in Oncology, 2023
Aggressiveness and age of manifestation of medullary thyroid cancer depend on the risk level of germline RET mutations. For high-risk mutations, preventive thyroidectomy is recommended at young age.
Yury Panaseykin   +8 more
doaj   +1 more source

Role of Twist1 transcription factor in thyroid tumor progression [PDF]

open access: yes, 2011
Thyroid carcinomas are the most common endocrine tumors in humans, with a globally increasing incidence. Differentiated tumors, such as papillary (PTC) and follicular (FTC) thyroid cancers, are often curable with surgical resection and radiotherapy ...
Bencivenga, Tammaro Claudio
core   +1 more source

Evaluation of Thyroid Nodules: Incidence and Distribution of Thyroid Cancer

open access: yesEndocrinology Research and Practice, 2022
Thyroid nodules are a common problem in clinical practice, they are usually benign; only about 5% of these nodules harbor malignancy. It is important to identify those that are likely to be malignant. The majority of thyroid cancers are papillary cancers,
Mehmet Fırat   +3 more
doaj   +2 more sources

Simultaneous Medullary and Papillary Thyroid Carcinoma with Lymph Node Metastasis in the Same Patient: Case Report and Review of the Literature

open access: yesAsian Journal of Surgery, 2005
We report a rare case of simultaneous medullary thyroid carcinoma on the left thyroid lobe with lymph node metastasis and papillary thyroid cancer on the right thyroid lobe.
Nidal Younes
doaj   +1 more source

Home - About - Disclaimer - Privacy